Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15083519 | Publishing Date : 14-Jan-2020 | No. of pages : 97
Detailed TOC of Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue
1.4 Market Analysis by Type
1.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human iPSCs
1.4.3 Mouse iPSCs
1.5 Market by Application
1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2020 VS 2026
1.5.2 Academic Research
1.5.3 Drug Development and Discovery
1.5.4 Toxicity Screening
1.5.5 Regenerative Medicine
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2015-2026)
2.2 Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Regions
2.2.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Induced Pluripotent Stem Cells (iPSCs) Historic Market Share by Regions (2015-2020)
2.2.3 Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Induced Pluripotent Stem Cells (iPSCs) Market Growth Strategy
2.3.6 Primary Interviews with Key Induced Pluripotent Stem Cells (iPSCs) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Market Size
3.1.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2015-2020)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2015-2020)
3.1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio
3.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2019
3.3 Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Area Served
3.4 Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
3.5 Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2015-2020)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2021-2026)
5 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application (2015-2026)
5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)
5.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020)
6.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in North America (2019-2020)
6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)
6.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020)
7.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Europe (2019-2020)
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)
7.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)
8 China
8.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020)
8.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in China (2019-2020)
8.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)
8.4 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020)
9.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Japan (2019-2020)
9.3 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)
9.4 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020)
10.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)
10.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)
11 India
11.1 India Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020)
11.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in India (2019-2020)
11.3 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)
11.4 India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size (2015-2020)
12.2 Induced Pluripotent Stem Cells (iPSCs) Key Players in Central & South America (2019-2020)
12.3 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)
12.4 Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Fujifilm Holding Corporation (CDI)
13.1.1 Fujifilm Holding Corporation (CDI) Company Details
13.1.2 Fujifilm Holding Corporation (CDI) Business Overview and Its Total Revenue
13.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction
13.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020))
13.1.5 Fujifilm Holding Corporation (CDI) Recent Development
13.2 Ncardia
13.2.1 Ncardia Company Details
13.2.2 Ncardia Business Overview and Its Total Revenue
13.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction
13.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
13.2.5 Ncardia Recent Development
13.3 Sumitomo Dainippon Pharma
13.3.1 Sumitomo Dainippon Pharma Company Details
13.3.2 Sumitomo Dainippon Pharma Business Overview and Its Total Revenue
13.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction
13.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
13.3.5 Sumitomo Dainippon Pharma Recent Development
13.4 Astellas Pharma Inc
13.4.1 Astellas Pharma Inc Company Details
13.4.2 Astellas Pharma Inc Business Overview and Its Total Revenue
13.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
13.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
13.4.5 Astellas Pharma Inc Recent Development
13.5 Fate Therapeutics, Inc
13.5.1 Fate Therapeutics, Inc Company Details
13.5.2 Fate Therapeutics, Inc Business Overview and Its Total Revenue
13.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
13.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
13.5.5 Fate Therapeutics, Inc Recent Development
13.6 Pluricell Biotech
13.6.1 Pluricell Biotech Company Details
13.6.2 Pluricell Biotech Business Overview and Its Total Revenue
13.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction
13.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
13.6.5 Pluricell Biotech Recent Development
13.7 Cell Inspire Biotechnology
13.7.1 Cell Inspire Biotechnology Company Details
13.7.2 Cell Inspire Biotechnology Business Overview and Its Total Revenue
13.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction
13.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
13.7.5 Cell Inspire Biotechnology Recent Development
13.8 ReproCELL
13.8.1 ReproCELL Company Details
13.8.2 ReproCELL Business Overview and Its Total Revenue
13.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction
13.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
13.8.5 ReproCELL Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Induced Pluripotent Stem Cells (iPSCs) Key Market Segments
Table 2. Key Players Covered: Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue
Table 3. Ranking of Global Top Induced Pluripotent Stem Cells (iPSCs) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Human iPSCs
Table 6. Key Players of Mouse iPSCs
Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2015-2020)
Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Induced Pluripotent Stem Cells (iPSCs) Market Growth Strategy
Table 17. Main Points Interviewed from Key Induced Pluripotent Stem Cells (iPSCs) Players
Table 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players (2015-2020)
Table 20. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2019)
Table 21. Global Induced Pluripotent Stem Cells (iPSCs) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Induced Pluripotent Stem Cells (iPSCs) Product Solution and Service
Table 24. Date of Enter into Induced Pluripotent Stem Cells (iPSCs) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Type (2015-2020)
Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2021-2026)
Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2015-2020)
Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020)
Table 34. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020)
Table 36. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020)
Table 38. Europe Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020)
Table 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020)
Table 42. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020)
Table 44. China Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020)
Table 46. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$)
Table 47. China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020)
Table 48. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$)
Table 49. China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020)
Table 50. Japan Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020)
Table 52. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020)
Table 54. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020)
Table 58. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020)
Table 60. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020)
Table 62. India Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020)
Table 64. India Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$)
Table 65. India Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020)
Table 66. India Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$)
Table 67. India Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Induced Pluripotent Stem Cells (iPSCs) Market Share (2019-2020)
Table 70. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2015-2020)
Table 72. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2015-2020)
Table 74. Fujifilm Holding Corporation (CDI) Company Details
Table 75. Fujifilm Holding Corporation (CDI) Business Overview
Table 76. Fujifilm Holding Corporation (CDI) Product
Table 77. Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$)
Table 78. Fujifilm Holding Corporation (CDI) Recent Development
Table 79. Ncardia Company Details
Table 80. Ncardia Business Overview
Table 81. Ncardia Product
Table 82. Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$)
Table 83. Ncardia Recent Development
Table 84. Sumitomo Dainippon Pharma Company Details
Table 85. Sumitomo Dainippon Pharma Business Overview
Table 86. Sumitomo Dainippon Pharma Product
Table 87. Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$)
Table 88. Sumitomo Dainippon Pharma Recent Development
Table 89. Astellas Pharma Inc Company Details
Table 90. Astellas Pharma Inc Business Overview
Table 91. Astellas Pharma Inc Product
Table 92. Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$)
Table 93. Astellas Pharma Inc Recent Development
Table 94. Fate Therapeutics, Inc Company Details
Table 95. Fate Therapeutics, Inc Business Overview
Table 96. Fate Therapeutics, Inc Product
Table 97. Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$)
Table 98. Fate Therapeutics, Inc Recent Development
Table 99. Pluricell Biotech Company Details
Table 100. Pluricell Biotech Business Overview
Table 101. Pluricell Biotech Product
Table 102. Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$)
Table 103. Pluricell Biotech Recent Development
Table 104. Cell Inspire Biotechnology Company Details
Table 105. Cell Inspire Biotechnology Business Overview
Table 106. Cell Inspire Biotechnology Product
Table 107. Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$)
Table 108. Cell Inspire Biotechnology Recent Development
Table 109. ReproCELL Business Overview
Table 110. ReproCELL Product
Table 111. ReproCELL Company Details
Table 112. ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020) (Million US$)
Table 113. ReproCELL Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2020 VS 2026
Figure 2. Human iPSCs Features
Figure 3. Mouse iPSCs Features
Figure 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2020 VS 2026
Figure 5. Academic Research Case Studies
Figure 6. Drug Development and Discovery Case Studies
Figure 7. Toxicity Screening Case Studies
Figure 8. Regenerative Medicine Case Studies
Figure 9. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 10. Global Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions: 2020 VS 2026
Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2019
Figure 15. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells (iPSCs) as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2019
Figure 17. North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Fujifilm Holding Corporation (CDI) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
Figure 26. Ncardia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
Figure 28. Sumitomo Dainippon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
Figure 30. Astellas Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Astellas Pharma Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
Figure 32. Fate Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Fate Therapeutics, Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
Figure 34. Pluricell Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
Figure 36. Cell Inspire Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
Figure 38. ReproCELL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
Keyplayers in Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2020-2026
Fujifilm Holding Corporation (CDI)Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL